Utilizing Precision Diagnostics to Identify High Risk Myeloma at Diagnosis and Relapse

A SkylineDx diagnostic test can help identify high-risk myeloma at diagnosis and relapse. Is this test right for you? How can you access it? Learn with us and come with your questions. 

SkylineDx is a biotechnology company, focused on the research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered in Rotterdam (the Netherlands) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory in San Diego (California). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of the disease or predict a patient’s response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient.